Dano Vaccines And Biologicals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 16-07-2024
- Paid Up Capital ₹ 5.61 Cr
as on 16-07-2024
- Company Age 40 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.60 Cr
as on 16-07-2024
- Satisfied Charges ₹ 24.27 Cr
as on 16-07-2024
- Revenue 19.45%
(FY 2023)
- Profit 22.67%
(FY 2023)
- Ebitda 12.67%
(FY 2023)
- Net Worth 18.17%
(FY 2023)
- Total Assets 12.85%
(FY 2023)
About Dano Vaccines And Biologicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.61 Cr.
The company currently has active open charges totaling ₹4.60 Cr. The company has closed loans amounting to ₹24.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suryanarayana Dantuluri, Dantuluri Raju, Dantuluri Raju, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231TG1984PTC005135
- Company No.
005135
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad.Andhra Pradesh, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dano Vaccines And Biologicals Pvt Ltd offer?
Dano Vaccines And Biologicals Pvt Ltd offers a wide range of products and services, including Injectable Products, Tetanus Vaccine.
Who are the key members and board of directors at Dano Vaccines And Biologicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryanarayana Dantuluri  | Managing Director | 27-Nov-1984 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dantuluri Raju | Director | 30-Sep-1996 | Current |
| Dantuluri Raju | Director | 26-Sep-1988 | Current |
| Sarojini Dantuluri | Director | 27-Nov-1984 | Current |
Financial Performance of Dano Vaccines And Biologicals.
Dano Vaccines And Biologicals Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 19.45% increase. The company also saw a substantial improvement in profitability, with a 22.67% increase in profit. The company's net worth Soared by an impressive increase of 18.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dano Vaccines And Biologicals?
In 2023, Dano Vaccines And Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 13 Sep 2022 | ₹0.48 M | Open |
Axis Bank Limited Creation Date: 25 Jun 2021 | ₹2.03 M | Open |
Axis Bank Limited Creation Date: 28 May 2019 | ₹1.94 M | Open |
How Many Employees Work at Dano Vaccines And Biologicals?
Dano Vaccines And Biologicals has a workforce of 50 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dano Vaccines And Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dano Vaccines And Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
